Board of Directors

The Board of Directors is responsible for the ultimate direction of the company and the supervision and oversight of Bellevue Group. It passes and periodically revises company strategy, issues directives and guidelines as necessary and determines Bellevue Group’s organizational structure and risk policies. 

Dr. Thomas von Planta

Präsident des Verwaltungsrates
read more

Dr. Thomas von Planta

Präsident des Verwaltungsrates
  • Degree in law, University of Basel, University of Geneva (Dr. iur.), attorney at law
  • Since 2006 owner / director of CorFinAd AG – Corporate Finance Advisory (M&A transactions and capital market financing)
  • 2002 – 2006 Bank Vontobel, Head of Corporate Finance, member of the extended executive board
  • 1992 – 2002 Goldman Sachs, ultimately in London, Equity Capital Markets Group & Investment Banking Division 

Dr. Daniel H. Sigg

Mitglied des Verwaltungsrates
read more

Dr. Daniel H. Sigg

Mitglied des Verwaltungsrates
  • Degree in law, University of Zurich, Dr. iur.
  • Since 2006 DHS International Advisors, LLC, Principal (advisor on financial issues)
  • 2000 – 2005 TimesSquare Capital Management Inc., President
  • 1997 – 1999 UBS, Global Head of Institutional Asset Management, Senior Managing Director
  • Mandates: Member of the Board of Directors of VP Bank, Member of the Board of Directors of Auerbach Grayson & Co.

Dr. Mirjam Staub-Bisang

Member of the Board
read more

Dr. Mirjam Staub-Bisang

Member of the Board
  • PhD in Law, University of Zurich, MBA INSEAD, Fontainebleau/Paris
  • Since 2005 CEO Indepedent Capital Group AG
  • Prior hedge funds asset management with Commerzbank, London; private equity investment management with Swiss Life Private Equity Partners, Zurich;  corporate development with industrial holding Quadrant, Zurich; investment banker with Merrill Lynch, London
  • Mandates: Member of the Board of Directors V-Zug AG, member of the Board of Directors of INSEAD, Fontainebleau/Singapore

Dr. Rupert Hengster

Member of the Board
read more

Dr. Rupert Hengster

Member of the Board
  • PhD in Law from the University of Salzburg and a master’s degree in business administration from the Vienna University of Economics and Business
  • Managing Partner and co-founder of Dr. Hengster, Loesch & Kollegen GmbH in Frankfurt
  • 2010–2013 CEO of Edmond de Rothschild Asset Management Deutschland in Frankfurt
  • 2004–2010 Managing Director and CEO of Sal. Oppenheim KAG in Cologne and Luxembourg
  • 1998–2004 Managing Director and CEO of WestLB Asset Management KAG in Düsseldorf

News

Markets & Opinions / 16.02.2018

BB Biotech publishes its annual report for 2017.

Products & Services / 08.02.2018

Bellevue seeks capital to invest in young, innovative, Swiss biotech companies.

Markets & Opinions / 25.01.2018

Read the current issue with a focus on gene therapies.

Corporate News / 23.01.2018

  Bellevue Group posts expected operating profit of about CHF 29 million, expected net pro...

Markets & Opinions / 19.01.2018

Mid caps overdeliver on innovation and are becoming a key upside trigger.